In QuotedData’s morning briefing for 3 July 2023
- Riverstone Energy (RSE) has provided an update on its share buyback program, whereby it has entered into an agreement with JPMorgan and Numis to buyback shares through a non-discretionary programme, subject to certain pre-set parameters. This programme will continue from today to the publishing of its next valuation (for the period end 30 June 2023) in July of this year. Since the initial announcement of RSE’s buyback programme on 5 May 2023, £12.8m worth of shares have been repurchased, leaving £29.5m left to be allocated.
- BioPharma Credit (BPCR) has provided an update on its investment in LumiraDax. On 30 June, LumiraDax filled a Form 6-K, which has implications on the loan agreements made between the two companies, specifically extending the time that LumiraDax has to comply with certain minimum net sales and minimum liquidity covenants in the Loan Agreement until July 17, 2023.